Resmed Inc. buy UBS Group AG
Start price
01.08.25
/
50%
€241.30
Target price
01.08.26
€284.77
Performance (%)
-31.77%
Price
18.06.26
€164.65
Summary
This prediction is currently active. Massive losses of -31.77% have been the result for the BUY prediction by UBS_Group_AG. This prediction currently runs until 01.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -0.903% | -0.903% |
| iShares Core DAX® | 1.750% | 2.660% |
| iShares Nasdaq 100 | 4.301% | 6.593% |
| iShares Nikkei 225® | 9.895% | 18.278% |
| iShares S&P 500 | 2.542% | 3.062% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at UBS Group AG from $285.00 to $325.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat